Article
Targeting High Glucose-Induced Epigenetic Modifications at Cardiac Levels: The Role of SGLT2 and SGLT2 Inhibitors
2022-11-29
Abstract excerpt
<h4>Background: </h4> Sodium-glucose co-transporters inhibitors showed many beneficial effects at the cardiovascular level. Several mechanisms of action have been identified. However, no data are reported on their capability to act via epigenetic mechanisms. Therefore, this study aimed to investigate the ability of SGLT2 inhibitors to induce protective effects at the cardiovascular level by acting on DNA methylati...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c1d67c74-3d6b-547c-bf4e-300799cc1057
- DOI
- 10.21203/rs.3.rs-2300456/v1
